vs
Assertio Holdings, Inc.（ASRT）与FIRST US BANCSHARES, INC.（FUSB）财务数据对比。点击上方公司名可切换其他公司
Assertio Holdings, Inc.的季度营收约是FIRST US BANCSHARES, INC.的1.3倍（$13.5M vs $10.4M），FIRST US BANCSHARES, INC.同比增速更快（7.1% vs -57.9%），过去两年FIRST US BANCSHARES, INC.的营收复合增速更高（2.6% vs -35.4%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
第一美国银行控股公司是一家银行控股企业，核心子公司第一公民银行在美国23个州经营着超过500家网点，另一家子公司硅谷银行则在15个州设有39个办事处，是美国规模较大的银行机构之一，总部位于北卡罗来纳州罗利。
ASRT vs FUSB — 直观对比
营收规模更大
ASRT
是对方的1.3倍
$10.4M
营收增速更快
FUSB
高出65.0%
-57.9%
两年增速更快
FUSB
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $10.4M |
| 净利润 | — | $2.1M |
| 毛利率 | — | — |
| 营业利润率 | -86.7% | 28.1% |
| 净利率 | — | 20.4% |
| 营收同比 | -57.9% | 7.1% |
| 净利润同比 | — | 24.2% |
| 每股收益（稀释后） | $-4.54 | $0.36 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTFUSB
| Q4 25 | $13.5M | $10.4M | ||
| Q3 25 | $49.5M | $10.5M | ||
| Q2 25 | $29.2M | $10.3M | ||
| Q1 25 | $26.5M | $9.8M | ||
| Q4 24 | $32.2M | $9.7M | ||
| Q3 24 | $29.2M | $10.1M | ||
| Q2 24 | $31.1M | $10.0M | ||
| Q1 24 | $32.4M | $9.9M |
净利润ASRTFUSB
| Q4 25 | — | $2.1M | ||
| Q3 25 | $11.4M | $1.9M | ||
| Q2 25 | $-16.4M | $155.0K | ||
| Q1 25 | $-13.5M | $1.8M | ||
| Q4 24 | — | $1.7M | ||
| Q3 24 | $-2.9M | $2.2M | ||
| Q2 24 | $-3.7M | $2.1M | ||
| Q1 24 | $-4.5M | $2.1M |
营业利润率ASRTFUSB
| Q4 25 | -86.7% | 28.1% | ||
| Q3 25 | 23.2% | 23.9% | ||
| Q2 25 | -27.5% | 1.6% | ||
| Q1 25 | -50.0% | 23.8% | ||
| Q4 24 | -41.9% | 23.8% | ||
| Q3 24 | -10.4% | 29.2% | ||
| Q2 24 | -11.6% | 27.4% | ||
| Q1 24 | -13.4% | 27.8% |
净利率ASRTFUSB
| Q4 25 | — | 20.4% | ||
| Q3 25 | 23.1% | 18.4% | ||
| Q2 25 | -56.0% | 1.5% | ||
| Q1 25 | -51.1% | 18.1% | ||
| Q4 24 | — | 17.6% | ||
| Q3 24 | -10.0% | 22.0% | ||
| Q2 24 | -11.8% | 21.2% | ||
| Q1 24 | -13.9% | 21.3% |
每股收益（稀释后）ASRTFUSB
| Q4 25 | $-4.54 | $0.36 | ||
| Q3 25 | $0.11 | $0.32 | ||
| Q2 25 | $-0.17 | $0.03 | ||
| Q1 25 | $-0.14 | $0.29 | ||
| Q4 24 | $-3.28 | $0.29 | ||
| Q3 24 | $-0.03 | $0.36 | ||
| Q2 24 | $-0.04 | $0.34 | ||
| Q1 24 | $-0.05 | $0.34 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | $73.5M |
| 总债务越低越好 | — | $10.9M |
| 股东权益账面价值 | $94.0M | $105.6M |
| 总资产 | $267.0M | $1.2B |
| 负债/权益比越低杠杆越低 | — | 0.10× |
8季度趋势，按日历期对齐
现金及短期投资ASRTFUSB
| Q4 25 | $63.4M | $73.5M | ||
| Q3 25 | $93.4M | $54.7M | ||
| Q2 25 | $98.2M | $54.0M | ||
| Q1 25 | $87.3M | $56.0M | ||
| Q4 24 | $100.1M | $47.2M | ||
| Q3 24 | $88.6M | $82.3M | ||
| Q2 24 | $88.4M | $58.2M | ||
| Q1 24 | $80.7M | $60.2M |
总债务ASRTFUSB
| Q4 25 | — | $10.9M | ||
| Q3 25 | — | $10.9M | ||
| Q2 25 | — | $10.9M | ||
| Q1 25 | — | $10.9M | ||
| Q4 24 | — | $10.9M | ||
| Q3 24 | — | $10.9M | ||
| Q2 24 | — | $10.8M | ||
| Q1 24 | $38.6M | $10.8M |
股东权益ASRTFUSB
| Q4 25 | $94.0M | $105.6M | ||
| Q3 25 | $105.8M | $104.2M | ||
| Q2 25 | $93.3M | $101.9M | ||
| Q1 25 | $108.5M | $101.2M | ||
| Q4 24 | $121.1M | $98.6M | ||
| Q3 24 | $130.5M | $98.5M | ||
| Q2 24 | $132.2M | $93.8M | ||
| Q1 24 | $134.5M | $92.3M |
总资产ASRTFUSB
| Q4 25 | $267.0M | $1.2B | ||
| Q3 25 | $319.8M | $1.1B | ||
| Q2 25 | $273.8M | $1.1B | ||
| Q1 25 | $286.4M | $1.1B | ||
| Q4 24 | $284.7M | $1.1B | ||
| Q3 24 | $276.0M | $1.1B | ||
| Q2 24 | $279.4M | $1.1B | ||
| Q1 24 | $282.0M | $1.1B |
负债/权益比ASRTFUSB
| Q4 25 | — | 0.10× | ||
| Q3 25 | — | 0.10× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | 0.11× | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | 0.29× | 0.12× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $12.3M |
| 自由现金流经营现金流 - 资本支出 | — | $9.1M |
| 自由现金流率自由现金流/营收 | — | 87.2% |
| 资本支出强度资本支出/营收 | — | 31.1% |
| 现金转化率经营现金流/净利润 | — | 5.79× |
| 过去12个月自由现金流最近4个季度 | — | $16.0M |
8季度趋势，按日历期对齐
经营现金流ASRTFUSB
| Q4 25 | $-30.0M | $12.3M | ||
| Q3 25 | $-4.8M | $4.2M | ||
| Q2 25 | $19.1M | $3.9M | ||
| Q1 25 | $-12.5M | $1.8M | ||
| Q4 24 | $11.5M | $7.8M | ||
| Q3 24 | $-35.0K | $1.9M | ||
| Q2 24 | $7.4M | $2.5M | ||
| Q1 24 | $7.5M | $825.0K |
自由现金流ASRTFUSB
| Q4 25 | — | $9.1M | ||
| Q3 25 | — | $3.6M | ||
| Q2 25 | — | $1.6M | ||
| Q1 25 | — | $1.7M | ||
| Q4 24 | — | $5.7M | ||
| Q3 24 | — | $1.3M | ||
| Q2 24 | — | $2.3M | ||
| Q1 24 | — | $-142.0K |
自由现金流率ASRTFUSB
| Q4 25 | — | 87.2% | ||
| Q3 25 | — | 34.2% | ||
| Q2 25 | — | 16.0% | ||
| Q1 25 | — | 17.2% | ||
| Q4 24 | — | 58.2% | ||
| Q3 24 | — | 12.7% | ||
| Q2 24 | — | 23.5% | ||
| Q1 24 | — | -1.4% |
资本支出强度ASRTFUSB
| Q4 25 | — | 31.1% | ||
| Q3 25 | — | 5.9% | ||
| Q2 25 | — | 21.8% | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | — | 21.6% | ||
| Q3 24 | 0.0% | 6.6% | ||
| Q2 24 | — | 2.0% | ||
| Q1 24 | — | 9.8% |
现金转化率ASRTFUSB
| Q4 25 | — | 5.79× | ||
| Q3 25 | -0.42× | 2.18× | ||
| Q2 25 | — | 25.16× | ||
| Q1 25 | — | 0.99× | ||
| Q4 24 | — | 4.53× | ||
| Q3 24 | — | 0.87× | ||
| Q2 24 | — | 1.20× | ||
| Q1 24 | — | 0.39× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
FUSB
暂无分部数据
